Lam Research (NASDAQ:LRCX) Upgraded at Wall Street Zen

Lam Research (NASDAQ:LRCX) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday.

A number of other research analysts also recently issued reports on the stock. TD Cowen lifted their price objective on shares of Lam Research from $100.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, July 31st. Wells Fargo & Company lifted their target price on shares of Lam Research from $98.00 to $135.00 and gave the stock an “equal weight” rating in a research note on Thursday. Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research note on Tuesday. Mizuho lifted their target price on shares of Lam Research from $120.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, September 12th. Finally, HSBC set a $127.00 target price on shares of Lam Research and gave the stock a “hold” rating in a research note on Tuesday. Twenty-three research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $119.20.

Lam Research Stock Down 0.8%

Shares of Lam Research stock opened at $145.81 on Friday. The firm’s 50 day moving average price is $110.47 and its 200-day moving average price is $92.27. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. Lam Research has a 52-week low of $56.32 and a 52-week high of $147.91. The company has a market cap of $183.87 billion, a P/E ratio of 35.05, a PEG ratio of 1.79 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. During the same quarter in the previous year, the firm earned $1.03 EPS. The company’s quarterly revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, sell-side analysts predict that Lam Research will post 3.71 EPS for the current fiscal year.

Institutional Investors Weigh In On Lam Research

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. KFA Private Wealth Group LLC purchased a new stake in Lam Research in the 3rd quarter worth $210,000. Jackson Wealth Management LLC increased its holdings in Lam Research by 1.7% in the 3rd quarter. Jackson Wealth Management LLC now owns 103,993 shares of the semiconductor company’s stock worth $13,925,000 after acquiring an additional 1,734 shares in the last quarter. Aaron Wealth Advisors LLC increased its holdings in Lam Research by 90.9% in the 3rd quarter. Aaron Wealth Advisors LLC now owns 24,382 shares of the semiconductor company’s stock worth $3,265,000 after acquiring an additional 11,612 shares in the last quarter. IMPACTfolio LLC purchased a new stake in Lam Research in the 3rd quarter worth $204,000. Finally, GAMMA Investing LLC increased its holdings in Lam Research by 12.1% in the 3rd quarter. GAMMA Investing LLC now owns 30,449 shares of the semiconductor company’s stock worth $4,077,000 after acquiring an additional 3,297 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.